Julia Teply-Szymanski

6PUBLICATIONS
50CO-AUTHORS
Medical mycologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 12, 2026
A pro-inflammatory metastasis-associated macrophage subset induces tumor-promoting mesothelial cell conversion in ovarian cancer via IL-1α secretion.

|Sep 02, 2026
Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial.

|Feb 19, 2026
mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR+/HER2- breast cancer.

Luise von Wichert, Alina Stroh, Marie Witt

|Jul 04, 2025
Stroma areactive invasion front areas (SARIFA) in 1,298 pT3/pT4 colorectal cancers: A strong prognostic parameter complementing established morphological criteria.

Sebastian Foersch, Nuwar Harb, Anne-Sophie Litmeyer

|Jun 23, 2025
Synergistic targeting of cancer cells through simultaneous inhibition of key metabolic enzymes.

Jan Dreute, Julia Stengel, Jonas Becher

|Apr 27, 2024
NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors-A Retrospective Molecular Tumor Board Analysis.

Niklas Gremke, Fiona R Rodepeter, Julia Teply-Szymanski

Pageof 1

Frequent Collaborators

4 joint publications

Thorsten Stiewe

3 joint publications

Niklas Gremke

2 joint publications

Carsten Denkert

2 joint publications

Johannes Graumann